no image available Dickens & Co. "Breakthrough Hope: FDA Approves Enzalutamide to Combat Aggressive Prostate Cancer" "New Treatment Option Brings Hope to Patients and Families Affected by Metastatic Castration-Resistant Prostate Cancer" Price: 22.00€